NCT06471803View on ClinicalTrials.gov

Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Atherosclerotic Cardiovascular Diseases
Trial Locations (1)

450018

Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Henan Province Clinical Research Center for Cardiovascular Diseases

OTHER